The Ninth China International Import Expo (CIIE) Closed in Shanghai on Tuesday

The ninth China International Import Expo (CIIE) closed in Shanghai on Tuesday after drawing exhibitors from a record 162 countries, regions, and international organizations.

Total deals reached at the six-day event are projected to be worth $85.45 billion over the coming year, up 2.3% from last year and a record high.

A total of 4,142 overseas companies took part in the Shanghai exhibition, with more than 480 representative products making global, Asian, or China debuts. The event featured expanded displays across artificial intelligence, commercial aerospace, and innovative pharmaceuticals.

The Bottom Line:

Total projected deals reached $85.45 billion, marking a 2.3% increase from last year.
Exhibitors spanned 162 countries, regions, and international organizations, featuring over 480 global or regional product debuts.
Major showcases included 6G terminal prototypes, autonomous vehicles, and novel therapeutics.

U.S. wireless chipmaker Qualcomm exhibited the world’s first 6G terminal prototype during the expo, marking the first time the device has been shown publicly outside the lab. The prototype supports joint tests conducted with China Mobile and ZTE to lay the groundwork for 6G chips and support the technology’s commercial rollout.

Shanghai calling! Join us for a global showcase at 9th China International Import Expo

Automotive innovation drew heavy attention as American electric vehicle company Tesla presented its Cybercab autonomous vehicle. The vehicle features no steering wheel or pedals, relying on cameras and AI to drive. Hexagon displayed its industrial humanoid robot AEON, while Chinese commercial aerospace company LandSpace featured its Zhuque-3 rocket, which utilizes a reusable booster capable of vertical landing.

The medical devices and health care exhibition area hosted several major Asian and Chinese product introductions. Pharmaceutical giant AstraZeneca debuted its new hypertension medication baxdrostat, an oral treatment that inhibits the enzyme aldosterone synthase. Novartis showcased ianalumab for treating Sjögren’s disease, and German optical giant Zeiss introduced its PT Lunana non-spherical lens for myopia correction.

9th China International Import Expo Opens in Shanghai

Danish pharmaceutical giant Novo Nordisk showcased new medicines including Kyinsu, a once-weekly injection for type 2 diabetes. Mike Doustdar, president and CEO of Novo Nordisk, stated that the event has become an important part of the company’s work in China.

Beyond hardware and pharmaceutical debuts, the expo facilitated extensive business matchmaking. A dedicated trade and investment conference connected more than 600 exhibitors and over 2,000 buyers from 59 countries and regions to sign cooperation agreements.

The Ninth China International Import Expo (CIIE) Closed in Shanghai on Tuesday — Photo: CCTV

First-time participants such as Austrian machine tool maker WFL Millturn Technologies utilized the platform to deepen industrial ties across the Asia-Pacific region. Meanwhile, French cosmetics giant L’Oréal used the venue as a launchpad, with Lan Zhenzhen, chief corporate affairs and engagement officer, L’Oréal North Asia & China, noting that nearly half of their brands debuted in the Chinese market through the CIIE.

Disclaimer: The information provided in this article is for educational and market analysis purposes only and does not constitute financial, investment, or legal advice. Always consult with a certified financial professional before making investment decisions.